GlassScriptPhysician profile
Olisa Ezegwu
NPI 1871089516
$1,527.24
in general payments reported to CMS, 2019-2025
9 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.13 · 2023: $397 · 2024: $838 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,259 · Education: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,258.53 |
| Education | $221.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $451.14 | 2023-2025 | Ensite, Mitraclip, Cardiomems |
| Abiomed | $375.16 | 2023-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $198.37 | 2022-2024 | Lifevest |
| Inari Medical, INC. | $166.37 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $155.51 | 2023-2025 | Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Medtronic, INC. | $65.82 | 2024-2025 | Corevalve Evolut R, Symplicity G3 |
| Alnylam Pharmaceuticals INC. | $53.45 | 2024 | Onpattro |
| Daxor Corporation | $37.52 | 2025 | Bva-100 |
| Angiodynamics, INC. | $23.90 | 2024 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olisa Ezegwu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.